JnJ

Rolaids Back on U.S. Store Shelves

Rolaids Intro-Sep13The U.S. division of Paris-based Sanofi (NYSE: SNY) announced on Monday that an iconic U.S. consumer product not named Twinkies is on its way back to...

5 Ways to Prevent Panic From Plundering Your Portfolio

With the stock market near its all-time high, few investors are terribly worried about their portfolios right now. But that makes it the best time to take steps to panic-proof your portfolio in preparation for the next financial crisis.

What a Wild Year It Was
for Health Care

Led by the health insurance reform law, a flurry of drug and food recalls, key medical breakthroughs and plenty of layoffs and lawsuits, 2010 proved to be an exciting -- if not always positive -- year. Here's our list of the year's biggest health stories.

Was Johnson & Johnson aware of problems with its Children's Tylenol months before the recall? The House Oversight Committee has invited an FDA commissioner and Johnson & Johnson chairman to a hearing next week to address this and other questions surrounding the massive recall of children's medicines earlier this year.

FDA Sends J&J Warning Letter on Two Products

In a warning letter to J&J's DePuy Orthopaedics, the FDA says it is illegally marketing its TruMatch CT scanner and Corail Hip System. This is the latest in a series of problems at J&J, which include a big children's Tylenol recall.

Toyota Needs to Move Fast to Save Brand

Crisis management experts say the time is now for Toyota to do everything possible to reassure the public that it's fixing the problems -- and that consumers should not lose faith in the carmaker's reputation for quality. But the company has miles to go to get to that point.